# Epidural and Intravenous Patient-Controlled Analgesia Following Lumbar Spinal Fusion Surgery

> **NCT03115151** · PHASE4 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 46 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Hydromorphone
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT03115151
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-08
- **Primary completion:** 2022-08-18
- **Final completion:** 2023-04-04
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** The surgical team has difficulty to find level 1 and 2 fusions for the study.
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03115151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03115151, "Epidural and Intravenous Patient-Controlled Analgesia Following Lumbar Spinal Fusion Surgery". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03115151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*